Rhea-AI Summary
Nemaura Medical (NASDAQ: NMRD) announces it will present at the Virtual Diabetes Technology Meeting on November 12, 2020. CEO Dr. Faz Chowdhury will discuss “CGM Usage for the Management and Reversal of Type 2 diabetes.” This year's event is virtual due to COVID-19, connecting technology developers for diabetes management solutions. Nemaura plans to launch proBEAT™ in December 2020, a non-invasive glucose monitor that provides AI-driven feedback to help manage diabetes. With over 88 million pre-diabetic and 25 million diabetic patients in the U.S., Nemaura aims to address this health crisis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
What is the current stock price of NEMAURA MEDICAL (NMRD)?
NEMAURA MEDICAL (NMRD) last closed at $0.000001.
What is the market cap of NEMAURA MEDICAL (NMRD)?
The market cap of NEMAURA MEDICAL (NMRD) is approximately $4.0K.